Document Type
Article
Publication Date
12-2001
Publication Title
Infection and Immunity
Department
Geisel School of Medicine
Abstract
Toxin-coregulated pilus (TCP) is a colonization factor required for cholera infection. It is not a strong immunogen when delivered in the context of whole cells, yet pilus subunits or TcpA derivative synthetic peptides induce protective responses. We examined the efficacy of immunizing mice with TCP conjugated to anti-class II monoclonal antibodies (MAb) with or without the addition of cholera toxin (CT) or anti-CD40 MAb to determine if the serologic response to TcpA could be manipulated. Anti-class II MAb-targeted TCP influenced the anti-TCP peptide serologic response with respect to titer and isotype. Responses to TcpA peptide 4 were induced with class II MAb-targeted TCP and not with nontargeted TCP. Class II MAb-targeting TcpA reduced the response to peptide 6 compared to the nontargeted TCP response. Class II MAb-targeted TcpA, if delivered with CT, enhanced the serologic response to TcpA peptides. The effectiveness of the combination of targeted TCP and CT was reduced if anti-CD40 MAb were included in the primary immunization. These data establish the need to understand the role of TCP presentation in the generation of B-cell epitopes in order to optimize TcpA-based cholera vaccines.
DOI
10.1128/IAI.69.12.7679-7686.2001
Original Citation
Wu JY, Taylor RK, Wade WF. Anti-class II monoclonal antibody-targeted Vibrio cholerae TcpA pilin: modulation of serologic response, epitope specificity, and isotype. Infect Immun. 2001 Dec;69(12):7679-86. doi: 10.1128/IAI.69.12.7679-7686.2001. PMID: 11705948; PMCID: PMC98862.
Dartmouth Digital Commons Citation
Wu, Jia-Yan; Taylor, Ronald K.; and Wade, William F., "Anti-Class II Monoclonal Antibody-Targeted Vibrio cholerae TcpA Pilin: Modulation of Serologic Response, Epitope Specificity, and Isotype" (2001). Dartmouth Scholarship. 973.
https://digitalcommons.dartmouth.edu/facoa/973
Included in
Digestive System Commons, Infectious Disease Commons, Medical Immunology Commons, Medical Microbiology Commons